• 2003

Company Description

NormOxys is a biotechnology company developing a new class of polyol phosphate-based small molecule drugs for the treatments of cancers.

NormOxys, Inc. operates as a biopharmaceutical company. It provides proprietary products that regulate the binding affinity between oxygen and hemoglobin. NormOxys, Inc. was formerly known as Oxyplus, Inc. and changed its name to NormOxys, Inc. in October 2008. The company was founded in 2003.